JP2024509276A5 - - Google Patents
Info
- Publication number
- JP2024509276A5 JP2024509276A5 JP2023555320A JP2023555320A JP2024509276A5 JP 2024509276 A5 JP2024509276 A5 JP 2024509276A5 JP 2023555320 A JP2023555320 A JP 2023555320A JP 2023555320 A JP2023555320 A JP 2023555320A JP 2024509276 A5 JP2024509276 A5 JP 2024509276A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- phosphate
- diffraction pattern
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159107P | 2021-03-10 | 2021-03-10 | |
| US63/159,107 | 2021-03-10 | ||
| US202163208641P | 2021-06-09 | 2021-06-09 | |
| US63/208,641 | 2021-06-09 | ||
| PCT/US2022/019776 WO2022192558A1 (en) | 2021-03-10 | 2022-03-10 | Salt and solid forms of a kinase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509276A JP2024509276A (ja) | 2024-02-29 |
| JP2024509276A5 true JP2024509276A5 (https=) | 2025-03-14 |
Family
ID=81074313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555320A Pending JP2024509276A (ja) | 2021-03-10 | 2022-03-10 | キナーゼ阻害剤の塩及び固体形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240254130A1 (https=) |
| EP (1) | EP4305036A1 (https=) |
| JP (1) | JP2024509276A (https=) |
| KR (1) | KR20240013720A (https=) |
| AU (1) | AU2022234314A1 (https=) |
| BR (1) | BR112023018246A2 (https=) |
| CA (1) | CA3211477A1 (https=) |
| CR (1) | CR20230479A (https=) |
| IL (1) | IL305791A (https=) |
| MX (1) | MX2023010606A (https=) |
| WO (1) | WO2022192558A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230391780A1 (en) * | 2020-10-14 | 2023-12-07 | Blueprint Medicines Corporation | Compositions and methods for treating kit- and pdgfra-mediated diseases |
| WO2024171143A1 (en) | 2023-02-17 | 2024-08-22 | Assia Chemical Industries Ltd. | Salts and solid forms of elenestinib |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021020441A2 (pt) | 2019-04-12 | 2021-12-14 | Blueprint Medicines Corp | Derivados de pirrolotriazina para tratar doenças mediadas por kit e pdgfra |
-
2022
- 2022-03-10 JP JP2023555320A patent/JP2024509276A/ja active Pending
- 2022-03-10 IL IL305791A patent/IL305791A/en unknown
- 2022-03-10 CA CA3211477A patent/CA3211477A1/en active Pending
- 2022-03-10 EP EP22714289.0A patent/EP4305036A1/en active Pending
- 2022-03-10 AU AU2022234314A patent/AU2022234314A1/en active Pending
- 2022-03-10 BR BR112023018246A patent/BR112023018246A2/pt unknown
- 2022-03-10 WO PCT/US2022/019776 patent/WO2022192558A1/en not_active Ceased
- 2022-03-10 MX MX2023010606A patent/MX2023010606A/es unknown
- 2022-03-10 US US18/549,769 patent/US20240254130A1/en active Pending
- 2022-03-10 CR CR20230479A patent/CR20230479A/es unknown
- 2022-03-10 KR KR1020237034550A patent/KR20240013720A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7241916B2 (ja) | ７ｈ－ピロロ［２，３－ｄ］ピリミジンｊａｋ－阻害剤 | |
| RU2745953C2 (ru) | Способ получения (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)-пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида и его солей | |
| ES2860676T3 (es) | Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol | |
| JP2021181497A (ja) | プリナブリン組成物 | |
| EP3842442A1 (en) | Compositions and methods for inhibiting arginase activity | |
| JP4628974B2 (ja) | イバブラジン塩酸塩のγ−結晶形態、その製造方法およびそれを含む医薬組成物 | |
| JP2010132669A (ja) | ストロンチウムラネレートのアルファー（α）−結晶形、その製造方法、及びそれを含む医薬組成物 | |
| WO2020052627A1 (zh) | 取代的吡咯并嘧啶类cdk抑制剂的盐及其结晶和用途 | |
| JP2022526438A5 (https=) | ||
| RU2007147427A (ru) | Кристаллические и другие формы солей, образованных из молочной кислоты и 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1н-бензимидазол-2-ил]-1н-хинолин-2-она | |
| US20250281492A1 (en) | New crystalline forms of salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide | |
| JP2024509276A5 (https=) | ||
| JP2009517353A5 (https=) | ||
| CN114057823B (zh) | 白桦脂酸衍生物，其制备方法、药物组合物和应用 | |
| US20210015817A1 (en) | Solid-state forms of abemaciclib, their use and preparation | |
| CN118439992A (zh) | 2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-n-苄基乙酰胺的固体形式 | |
| TWI705065B (zh) | 嗎啉衍生物的鹽及其晶型、其製備方法及藥物組成物、用途 | |
| JP3830816B2 (ja) | アザビシクロ（２．２．２）オクタン−３−アミンクエン酸塩の結晶多形及びそれらの医薬組成物 | |
| JP2003501353A (ja) | Ｎｋ−１受容体アンタゴニストとしての（２−ベンズヒドリル−１−アザビシクロ［２．２．２］オクト−３−イル）−（５−イソプロピル−２−メトキシベンジル）−アミンクエン酸塩の結晶多形 | |
| JP4267447B2 (ja) | 細胞増殖抑制作用を有するランタン化合物 | |
| JP4826051B2 (ja) | スチルベン誘導体の新規結晶及びその製造方法 | |
| WO2025256556A1 (zh) | Protac嵌合化合物的固体形式、其制备方法、药物组合物和用途 | |
| JP2024518370A (ja) | （ｒ）－オキシブチニンｄ－リンゴ酸塩の固体形態 | |
| RU2008125299A (ru) | Кристаллические f-, g-, h-, i- и к-формы иматинибмезилата | |
| ES2391738B1 (es) | Sales de tramadol y diflunisal y su forma cristalina en el tratamiento del dolor |